The current valuation score of Silence Therapeutics PLC is 7.77, ranking 144 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -6.60, which is -60.20% below the recent high of -2.63 and -827.16% above the recent low of -61.22.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.